DE602004009696D1 - Immunosuppressive wirkungen von pteridinderivativen - Google Patents
Immunosuppressive wirkungen von pteridinderivativenInfo
- Publication number
- DE602004009696D1 DE602004009696D1 DE602004009696T DE602004009696T DE602004009696D1 DE 602004009696 D1 DE602004009696 D1 DE 602004009696D1 DE 602004009696 T DE602004009696 T DE 602004009696T DE 602004009696 T DE602004009696 T DE 602004009696T DE 602004009696 D1 DE602004009696 D1 DE 602004009696D1
- Authority
- DE
- Germany
- Prior art keywords
- disorders
- derivatives
- useful
- treatment
- pteridine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/10—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with an aromatic or hetero-aromatic ring directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/651,604 US7276506B2 (en) | 1998-12-28 | 2003-08-29 | Immunosuppressive effects of pteridine derivatives |
US651604 | 2003-08-29 | ||
GB0408955A GB2413324A (en) | 2004-04-22 | 2004-04-22 | Pharmaceutically active pteridine derivatives |
GB0408955 | 2004-04-22 | ||
PCT/BE2004/000124 WO2005021003A2 (en) | 2003-08-29 | 2004-08-27 | Immunosuppressive effects of pteridine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602004009696D1 true DE602004009696D1 (de) | 2007-12-06 |
DE602004009696T2 DE602004009696T2 (de) | 2008-08-28 |
Family
ID=34276842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004009696T Expired - Fee Related DE602004009696T2 (de) | 2003-08-29 | 2004-08-27 | Immunosuppressive wirkungen von pteridinderivativen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1658081B1 (de) |
AT (1) | ATE376421T1 (de) |
AU (1) | AU2004267885A1 (de) |
CA (1) | CA2534151A1 (de) |
CY (1) | CY1107264T1 (de) |
DE (1) | DE602004009696T2 (de) |
DK (1) | DK1658081T3 (de) |
ES (1) | ES2295897T3 (de) |
PL (1) | PL1658081T3 (de) |
WO (1) | WO2005021003A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7276506B2 (en) | 1998-12-28 | 2007-10-02 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
AU2006283592A1 (en) | 2005-08-22 | 2007-03-01 | Amgen Inc. | Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
US20090318456A1 (en) * | 2006-07-06 | 2009-12-24 | Gilead Sciences, Inc. | Substituted pteridines for the treatment and prevention of viral infections |
US9259426B2 (en) | 2006-07-20 | 2016-02-16 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
US10144736B2 (en) * | 2006-07-20 | 2018-12-04 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
CN101569617A (zh) * | 2009-06-11 | 2009-11-04 | 辽宁利锋科技开发有限公司 | 具有金刚烷结构药物及其衍生物和类似物抗肿瘤新适应症的应用 |
AU2012262014B2 (en) * | 2011-06-01 | 2016-07-14 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
EA035093B1 (ru) | 2015-03-04 | 2020-04-27 | Джилид Сайэнс, Инк. | 4,6-диаминопиридо[3,2-d]пиримидиновые соединения, модулирующие toll-подобные рецепторы |
WO2018045150A1 (en) | 2016-09-02 | 2018-03-08 | Gilead Sciences, Inc. | 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators |
AU2017318601B2 (en) | 2016-09-02 | 2020-09-03 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202212339A (zh) | 2019-04-17 | 2022-04-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
CN114984019B (zh) * | 2022-07-15 | 2023-08-22 | 山东中医药大学 | 一种铁死亡抑制剂化合物及在肝损伤修复领域的应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB785353A (en) * | 1953-01-30 | 1957-10-30 | Merck & Co Inc | Substituted pteridine derivatives |
US2940972A (en) * | 1957-06-27 | 1960-06-14 | Thomae Gmbh Dr K | Tri-and tetra-substituted pteridine derivatives |
US3081230A (en) * | 1960-09-08 | 1963-03-12 | Smith Kline French Lab | Diuretic and antihypertensive triaminoarylpteridines |
US3159628A (en) * | 1962-05-28 | 1964-12-01 | Smith Kline French Lab | Pteridine-5-oxide derivatives |
DE1921308A1 (de) * | 1969-04-25 | 1971-01-07 | Boehringer Sohn Ingelheim | Herzwirksame Zubereitungen |
US3859287A (en) * | 1971-05-05 | 1975-01-07 | Walter Wesley Parish | Thiopteridines and process for producing same |
DE3323932A1 (de) * | 1983-07-02 | 1985-01-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue 2-piperazino-pteridine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel |
DE3445298A1 (de) * | 1984-12-12 | 1986-06-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel |
DD267495A1 (de) * | 1987-11-11 | 1989-05-03 | Akad Wissenschaften Ddr | Verfahren zur herstellung eines neuen methotrexat-derivates mit verminderter toxizitaet |
DE4009941A1 (de) * | 1990-03-28 | 1991-10-02 | Thomae Gmbh Dr K | Verwendung von pteridinen zur sensibilisierung resistenter plasmodien bei der malaria-chemotherapie und diese verbindungen enthaltende arzneimittel |
WO2000039129A1 (en) * | 1998-12-28 | 2000-07-06 | K.U. Leuven Research & Development | Immunosuppressive effects of pteridine derivatives |
US6946465B2 (en) * | 1999-02-02 | 2005-09-20 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
DE19944767A1 (de) * | 1999-09-17 | 2001-03-29 | Vasopharm Biotech Gmbh & Co Kg | N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
SE0003828D0 (sv) * | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Novel compounds |
DE10202468A1 (de) * | 2002-01-23 | 2004-09-30 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung |
EP1663244B1 (de) * | 2003-09-12 | 2007-08-15 | 4 Aza Ip Nv | Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha |
-
2004
- 2004-08-27 DK DK04761485T patent/DK1658081T3/da active
- 2004-08-27 CA CA002534151A patent/CA2534151A1/en not_active Abandoned
- 2004-08-27 EP EP04761485A patent/EP1658081B1/de not_active Expired - Lifetime
- 2004-08-27 AT AT04761485T patent/ATE376421T1/de not_active IP Right Cessation
- 2004-08-27 WO PCT/BE2004/000124 patent/WO2005021003A2/en active IP Right Grant
- 2004-08-27 DE DE602004009696T patent/DE602004009696T2/de not_active Expired - Fee Related
- 2004-08-27 AU AU2004267885A patent/AU2004267885A1/en not_active Abandoned
- 2004-08-27 PL PL04761485T patent/PL1658081T3/pl unknown
- 2004-08-27 ES ES04761485T patent/ES2295897T3/es not_active Expired - Lifetime
-
2008
- 2008-01-10 CY CY20081100034T patent/CY1107264T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE602004009696T2 (de) | 2008-08-28 |
PL1658081T3 (pl) | 2008-03-31 |
EP1658081A2 (de) | 2006-05-24 |
ATE376421T1 (de) | 2007-11-15 |
DK1658081T3 (da) | 2008-02-25 |
EP1658081B1 (de) | 2007-10-24 |
CA2534151A1 (en) | 2005-03-10 |
CY1107264T1 (el) | 2012-11-21 |
AU2004267885A1 (en) | 2005-03-10 |
WO2005021003A3 (en) | 2005-06-09 |
ES2295897T3 (es) | 2008-04-16 |
WO2005021003A2 (en) | 2005-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107264T1 (el) | Αποτελεσματα καταστολης ανοσοποιησης των παραγωγων pteridine | |
DK1673092T3 (da) | Heterocyklylsubstituerede pteridinderivater og anvendelsen deraf i terapi | |
ATE422496T1 (de) | Als medikamente für die behandlung von autoimmunerkrankungen geeignete substituierte pyridoä2,3-düpyrimidinderivate | |
WO2006069805A3 (en) | Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment | |
WO2009003669A3 (en) | Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment | |
BRPI0418112A (pt) | inibidores de p-38 quinase bicìclico heterocìclicos | |
BR0316256A (pt) | Métodos de inibir a produção de tnf-alfa e a atividade de pde4, de tratar ou prevenir uma doença ou um distúrbio, de controlar os nìveis de camp em uma célula e de produzir um composto, composição farmacêutica e composto | |
TW200738660A (en) | Piperidinyl derivatives as modulators of chemokine receptor activity | |
ATE482213T1 (de) | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine | |
NO20051966L (no) | Nye pyrimidinamidderivater og anvendelse derav | |
DE50311449D1 (de) | Verwendung von folaten zur herstellung einer zubereitung geeignet zur vorbeugung und behandlung von ammationsmarker crp und saa | |
DE602004008304D1 (de) | Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
PA8583601A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
ATE403433T1 (de) | Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen | |
ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
ATE418550T1 (de) | 8-(1-piperazinyl)-chinolinderivate und deren verwendung bei der behandlung von zns- erkrankungen | |
NO20055517L (no) | 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
DE60327335D1 (de) | Alpha 2b oder 2b/2c adrenozeptor-agonisten zur behandlung von morbus alzheimer und morbus parkinson | |
TW200505448A (en) | 5-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents | |
BRPI0516373A (pt) | derivados de pirido(3,2-d)pirimidinas e uso dos mesmos | |
DE602004010186D1 (de) | Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2 | |
DE602004025849D1 (de) | Behandlung von schwerer aphasie bei chronischen zerebrovaskulären erkrankungen | |
EP1878728A3 (de) | Derivate von Piperazin und dessen höheren Homologen zur Behandlung von Krankheiten, die mit Entzündungen einhergehen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |